{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:33:23Z","timestamp":1790685203038,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015187","name":"Lake Champlain Cancer Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016939","name":"Myriad Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.prro.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:10:39Z","timestamp":1603235439000},"page":"13-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline"],"prefix":"10.1016","volume":"11","author":[{"given":"Jennifer Y.","family":"Wo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishin A.","family":"Bhadkamkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2703-0501","authenticated-orcid":false,"given":"Lisa","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dorth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Garcia-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Jacqmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"Raldow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ruiz-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn B.","family":"Stitzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q. Jackie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2020.08.004_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.prro.2015.11.014","article-title":"Appropriate customization of radiation therapy for stage II and III rectal cancer: executive summary of an ASTRO Clinical Practice Statement using the RAND\/UCLA Appropriateness Method","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/SLA.0000000000001193","article-title":"Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II Study","volume":"263","author":"Battersby","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(09)70381-X","article-title":"Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial","volume":"11","author":"Chua","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bjs.10879","article-title":"Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial","volume":"105","author":"Ruppert","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2012.45.3258","article-title":"Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study","volume":"32","author":"Taylor","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib7","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib8","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib9","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial\u00a0after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2020.08.004_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"Van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib12","article-title":"Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma","volume":"10","author":"Abraha","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2020.08.004_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","article-title":"Preoperative radiotherapy for resectable rectal cancer: a meta-analysis","volume":"284","author":"Camma","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2020.08.004_bib14","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1245\/s10434-013-3198-9","article-title":"Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials","volume":"20","author":"Rahbari","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"Peeters","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3857\/roj.2017.00059","article-title":"Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials","volume":"35","author":"Song","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2020.08.004_bib17","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/cncr.25943","article-title":"Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2020.08.004_bib18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2020.08.004_bib19","unstructured":"Califano JL, WM; Nehal, KS, et\u00a0al. AJCC Cancer Staging Manual. In: Amin MES, Greene F, et\u00a0al, ed. American Joint Committee on Cancer Staging Manual, Eighth Edition. Springer International Publishing; 2018:178-179."},{"key":"10.1016\/j.prro.2020.08.004_bib20","series-title":"MRI Primary Rectal Cancer Staging Template - SAR Rectal\/Anal Cancer DFP 2019. Rectal and Anal Cancer DFP","author":"Society","year":"2019"},{"key":"10.1016\/j.prro.2020.08.004_bib21","article-title":"Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer","volume":"2","author":"De Caluwe","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2020.08.004_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ctrv.2010.03.002","article-title":"Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data","volume":"36","author":"Fiorica","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.prro.2020.08.004_bib23","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","article-title":"Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer","volume":"26","author":"Braendengen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib25","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"G\u00e9rard","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib27","article-title":"Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04","volume":"32","author":"O\u2019Connell","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000367972","article-title":"Phase II study of preoperative concurrent chemoradiotherapy with S-1 plus bevacizumab for locally advanced resectable rectal adenocarcinoma","volume":"88","author":"Sadahiro","year":"2015","journal-title":"Oncology"},{"key":"10.1016\/j.prro.2020.08.004_bib29","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1200\/JCO.2016.66.6198","article-title":"Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial","volume":"34","author":"Deng","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejca.2015.10.060","article-title":"The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)","volume":"55","author":"McLachlan","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2020.08.004_bib32","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib33","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2014a Dutch colorectal cancer group study","volume":"23","author":"Peeters","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2007.07.007","article-title":"Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial","volume":"84","author":"Pietrzak","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib35","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1200\/JCO.2009.26.5264","article-title":"Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07\/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial","volume":"28","author":"Stephens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib36","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1245\/s10434-017-5897-0","article-title":"Short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical treatment in primary stage IV rectal cancer: long-term results of a phase II study","volume":"24","author":"Bisschop","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e3182196e1f","article-title":"Optimal timing of surgery after chemoradiation for advanced rectal cancer: Preliminary results of a multicenter, nonrandomized phase II prospective trial","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib38","first-page":"697","article-title":"A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer","volume":"119","author":"Gollins","year":"2018","journal-title":"COPERNICUS"},{"key":"10.1016\/j.prro.2020.08.004_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijrobp.2017.05.048","article-title":"Improved metastasis- and disease-free survival with preoperative sequential short-course radiation therapy and FOLFOX chemotherapy for rectal cancer compared with neoadjuvant long-course chemoradiotherapy: results of a matched pair analysis","volume":"99","author":"Markovina","year":"2017","journal-title":"In J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.prro.2020.08.004_bib40","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","article-title":"Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trialdagger","volume":"26","author":"Fernandez-Martos","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0000000000000368","article-title":"Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies","volume":"263","author":"Petrelli","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6756859","article-title":"Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcome for rectal cancer: a systematic review\u00a0and meta-analysis","volume":"2016","author":"Wang","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.prro.2020.08.004_bib43","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/bjs.10984","article-title":"Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer","volume":"105","author":"Akgun","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib44","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib45","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","article-title":"Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6)","volume":"34","author":"Lefevre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib46","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.ejca.2013.05.025","article-title":"Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients","volume":"49","author":"van den Broek","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2020.08.004_bib47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib48","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"Aschele","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib49","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S2468-1253(18)30301-7","article-title":"Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis","volume":"3","author":"Chadi","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.prro.2020.08.004_bib51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/SLA.0000000000002761","article-title":"Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis","volume":"268","author":"Dattani","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.prro.2020.08.004_bib53","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/DCR.0000000000000862","article-title":"Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection - a matched-controlled study","volume":"60","author":"Hupkens","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2020.08.004_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2020.08.004_bib55","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S1470-2045(15)00215-6","article-title":"Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamasurg.2018.3752","article-title":"Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study","volume":"154","author":"Stijns","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib58","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","article-title":"Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment","volume":"22","author":"Maas","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0000000000003286","article-title":"Conditional survival in patients with rectal cancer and complete clinical response managed by watch and wait after chemoradiation: recurrence risk over time","volume":"272","author":"Sao Juliao","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12029-017-0041-8","article-title":"Is it possible a conservative approach after radiochemotherapy in locally advanced rectal cancer (LARC)? A systematic review of the literature and meta-analysis","volume":"50","author":"Fiorica","year":"2019","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.prro.2020.08.004_bib61","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00384-016-2709-0","article-title":"Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy","volume":"32","author":"Kim","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.prro.2020.08.004_bib62","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/DCR.0000000000001166","article-title":"Patient and physician preferences for nonoperative management for low rectal cancer: is it a reasonable treatment option?","volume":"61","author":"Kennedy","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2020.08.004_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/bjc.2016.417","article-title":"Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer","volume":"116","author":"Creavin","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2020.08.004_bib64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/DCR.0000000000000543","article-title":"Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation","volume":"59","author":"Habr-Gama","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2020.08.004_bib65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2020.08.004_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw171","article-title":"Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer","volume":"108","author":"Martens","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2020.08.004_bib67","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DCR.0b013e3182a25c4e","article-title":"Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?","volume":"56","author":"Habr-Gama","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2020.08.004_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.radonc.2018.12.024","article-title":"A systematic review and meta-analysis of pT2 rectal cancer spread and recurrence pattern: Implications for target design in radiation therapy for organ preservation","volume":"133","author":"Socha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib71","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2006.02.050","article-title":"Definition and delineation of the clinical target volume for rectal cancer","volume":"65","author":"Roels","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.08.004_bib72","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jjco\/hyy029","article-title":"Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity","volume":"48","author":"Wee","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib73","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/s12885-015-1812-x","article-title":"Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3-D conformal radiotherapy","volume":"15","author":"Droge","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2020.08.004_bib74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fonc.2017.00225","article-title":"Comparative analysis of efficacy, toxicity, and patient-reported outcomes in rectal cancer patients undergoing preoperative 3-D conformal radiotherapy or VMAT","volume":"7","author":"Regnier","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib75","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/0284186X.2017.1350286","article-title":"Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer","volume":"56","author":"Stuyck","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib76","first-page":"129","article-title":"Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer","volume":"6","author":"Yang","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.prro.2020.08.004_bib77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.radonc.2016.09.010","article-title":"Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer","volume":"121","author":"Ng","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00384-006-0166-x","article-title":"Intensity-modulated radiotherapy with a belly board for rectal cancer","volume":"22","author":"Kim","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.prro.2020.08.004_bib79","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00066-018-1324-0","article-title":"A treatment planning study of prone vs. supine positions for locally advanced rectal\u00a0carcinoma: comparison of 3-dimensional conformal radiotherapy,\u00a0tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy","volume":"194","author":"Scobioala","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2020.08.004_bib80","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4103\/0973-1482.138021","article-title":"A comparative study of set up variations and bowel volumes in supine versus prone positions of patients treated with external beam radiation for carcinoma rectum","volume":"10","author":"Rajeev","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.prro.2020.08.004_bib81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13014-014-0296-1","article-title":"Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?","volume":"9","author":"Yeo","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2020.08.004_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2015.05.005","article-title":"NRG Oncology Radiation Therapy Oncology Group 0822: A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer","volume":"93","author":"Hong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.08.004_bib83","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ijrobp.2011.05.027","article-title":"Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer","volume":"82","author":"Wong","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.08.004_bib84","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850020302071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850020302071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:23:04Z","timestamp":1761819784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850020302071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1879850020302071"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2020.08.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}